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Although wild chimpanzees and other African great apes live in regions endemic for African sleeping
sickness, very little is known about their trypanosome infections, mainly due to major difﬁculties in
obtaining their blood samples. In present work, we established a diagnostic ITS1-based PCR assay that
allows detection of the DNA of all four Trypanosoma brucei subspecies (Trypanosoma brucei brucei, Try-
panosoma brucei rhodesiense, Trypanosoma brucei gambiense, and Trypanosoma brucei evansi) in feces of
experimentally infected mice. Next, using this assay we revealed the presence of trypanosomes in the
fecal samples of wild chimpanzees and this ﬁnding was further supported by results obtained using a set
of primate tissue samples. Phylogenetic analysis of the ITS1 region showed that the majority of obtained
sequences fell into the robust T. brucei group, providing strong evidence that these infections were
caused by T. b. rhodesiense and/or T. b. gambiense. The optimized technique of trypanosome detection in
feces will improve our knowledge about the epidemiology of trypanosomes in primates and possibly also
other endangered mammals, from which blood and tissue samples cannot be obtained.
Finally, we demonstrated that the mandrill serum was able to efﬁciently lyse T. b. brucei and T. b.
rhodesiense, and to some extent T. b. gambiense, while the chimpanzee serum failed to lyse any of these
subspecies.
© 2015 The Authors. Published by Elsevier Ltd on behalf of Australian Society for Parasitology. This is an
open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
African trypanosomes of the Trypanosoma brucei group are the
causative agents of sleeping sickness and nagana (Simarro et al.,
2011). T. brucei has been found throughout sub-Saharan Africaranisovska 31, 37005, Ceske
Ltd on behalf of Australian Society fand comprises three morphologically identical but genetically
different subspecies, speciﬁcally Trypanosoma brucei brucei, Try-
panosoma brucei rhodesiense, and Trypanosoma brucei gambiense
(Tait et al., 2011), and Trypanosoma brucei evansi (Lai et al., 2008).
Except the last one, these subspecies are transmitted by tsetse ﬂies
of the genus Glossina (Franco et al., 2014), with T. b. gambiense and
T. b. rhodesiense, causing the West-African and East-African human
sleeping sickness, respectively, both being lethal, yet having
distinct clinical syndromes (Brun et al., 2010).or Parasitology. This is an open access article under the CC BY-NC-ND license (http://
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to trypanolytic factors found in human serum, whereas other two
subspecies responsible for human trypanosomiasis, T. b. gambiense
and T. b. rhodesiense, have developed mechanisms for escaping from
lysis mediated by the trypanosome lytic factor (TLF) (Lugli et al.,
2004; Wheeler, 2010), which is primarily composed of Apolipo-
protein L1 (ApoL1) and a haptoglobin-related protein (Raper and
Friedman, 2013). Both trypanosomes able to infect humans exhibit
different ways of developing the TLF-mediated lysis. In the case of T.
b. gambiense, the resistance is achieved by the interplay among a
unique modiﬁcation of the TLF receptor, expression of a speciﬁc
TgSGP glycoprotein, and changes in lysosomal physiology (Uzureau
et al., 2013). T. b. rhodesiense developed the serum-resistance-
associated protein, which is alone sufﬁcient to confer complete
resistance to the human TLF (Xong et al., 1998; Vanhollebeke and
Pays, 2010; Stephens et al., 2012). The sera of some non-human
primates (baboons, sooty mangabeys, mandrills and gorillas) were
shown to be capable of ApoL1-mediated killing of the ﬂagellates,
while the serum of chimpanzees showed no trypanolytic activity
due to secondary loss of the ApoL1 gene (Lugli et al., 2004;
Poelvoorde et al., 2004; Thomson et al., 2009, 2014). Moreover,
early studies showed that experimental infections with T. b. rhode-
siense and T. b. brucei mostly caused the death of untreated chim-
panzees, while infections with T. b. gambiensewere mild and did not
result in apparent clinical symptoms (Baker, 1962, 1968; Baker and
Taylor, 1971; Godfrey and Killick-Kendrick, 1967; Hoare, 1972).
Within recent years, with the advent of genetic characterization,
molecular markers have been developed to study the genetic di-
versity of trypanosomes (Tait et al., 2011). These methods, such as
determination of microsatellite markers for determination of allelic
variations, demonstrated great diversity of the T. brucei group in
humans due to frequent genetic exchange (Capewell et al., 2013a;
Duffy et al., 2014). Recently, Echodu et al. (2015) showed the
emergence of the human infective strains from the non-infective
T. b. brucei strains of different genetic backgrounds and high-
lighted the importance of cattle as possible reservoir of sleeping
sickness. Moreover, Capewell et al. (2013a) revealed the existence
of hybrids of T. b. gambiense and T. b. brucei with novel resistance
mechanism, which are able to infect humans. These facts showed
the importance of research on the trypanosomatids in other
mammalian host, especially free-ranging non-human primates.
Obtaining blood samples from wild African apes is complicated
and inmost cases ethically unacceptable (Leendertz et al., 2006). As
a result, the blood and tissue samples have been collected mostly
from chimpanzees and other primates that died of anthrax or res-
piratory diseases in the Taï National Park (NP), Ivory Coast
(Leendertz et al., 2004; Kondgen et al., 2010) have been screened
for the presence of Trypanosoma spp. Being aware of the break-
throughs in our understanding of the evolution of human Plasmo-
dium species precipitated by their detection in feces of African apes
(Kaiser et al., 2010), we designed an assay capable of amplifying
trypanosome DNA from this material.
2. Methods
2.1. Ethics statement
General permission for sample collection from deceased wild
primateswasobtained fromtheauthorities in chargeof Co^te d'Ivoire,
Guinea, Uganda, and Democratic Republic of Congo. Deceased ani-
mals were found during the course of a long term project focused
on the behavior and infectious diseases in wild primates (Leendertz
et al., 2006). No animal was anaesthetized or handled for the
sole purpose of sample collection. Fecal samples were collected
without disturbing the animals within 2e3 min after defecation.All samples from African sanctuary-living wild-born great apes
were collected during routine health checks by the sanctuary on-
site veterinarians. Since no animal was sampled speciﬁcally for
this study, approval from the relevant institutional committee was
not needed. All samples were collected according to the guidelines
- Chimpanzee sanctuaries: guidelines and management workshop
report (available at http://pages.ucsd.edu/~jmoore/courses/methp
rimconsweb08/chimpsanct.pdf; date of access to website in 2004).
All sera from animals living in Czech zoological gardens were
collected during preventive veterinary health checks. No animal
was sampled speciﬁcally for this study. All samples were collected
in accordance with legal requirements of the Czech Republic (Act
no. 161/1992) and with the rules of the respective zoos. Samples
collected during necropsies of primates that died from various
causes in zoos and primate facilities were also included.
Imports of samples from free-ranging chimpanzees proceeded
according to German veterinary regulations for import of organic
materials. Tissue and blood samples were exported with the
appropriate CITES permissions from the respective country and
Germany. No permit was needed for transport between labora-
tories in Germany and Czech Republic as both are members of
European Union. The experimental infection of mice was approved
by the Ethical Committees of the Czech Ministry of Education and
Biology Centre (no. 90/2013).
2.2. Detection of trypanosomes in feces of experimentally infected
mice
Four laboratory mice were infected with T. b. brucei (STIB 920),
T. b. rhodesiense (Etat 1.2 R variant), T. b. gambiense (LiTat 1.3) and
T. b. evansi (STIB805) by intraperitoneal inoculation of 105 blood-
stream stages (trypomastigotes), and the course of infection was
controlled by searching for the ﬂagellates in blood smears obtained
as a drop from the tail. First search for the presence of parasites was
performed 72 h post-infection and continued until trypomastigotes
appeared in the blood every 8 h. At that time, fecal and blood
samples were collected and used for isolation of total DNA using
protocols described below.
Blood samples were placed on a ﬁlter paper for ethanol evap-
oration and total DNA was isolated by incubation in a 200 mL vol-
ume with Chelex 100 (SigmaeAldrich, St. Louis, MO, USA) (ﬁnal
concentration 5%) at 56 C for 1 h, followed by boiling for 10 min.
Before use, samples were centrifuged for 1 min at 15,000 rpm, and
2.5 mL of supernatant was used for PCR. DNA from fecal samples was
isolated by a commercial stool kit (Qiagen, Venlo, Limburg,
Netherlands). PCR and sequencing were performed for each sample
at least in triplicate and, to avoid contamination, in a laboratory
that does not work with trypanosomes, always with positive and
negative controls included.
A nested approach was used to amplify a region of the Internal
Transcribed Spacer 1 (ITS-1) of Trypanosoma spp. (~180-640 bp).
Primers Tryp_3 (50- TGCAATTATTGGTCGCGC -30) and Tryp_4 (50-
CTTTGCTGCGTTCTT -30) were used for the ﬁrst round of PCR, while
internal primers Tryp_1 (50- AAGCCAAGTCATCCATCG -30) and
Tryp_2 (50- TAGAGGAAGCAAAAG -30) were used for the second
round of PCR (Adams et al., 2006). PCR was performed with Taq-
polymerase (TopBio, Prague, Czech Republic) using the following
program: 1 min at 95 C, 35 cycles of 1 min at 94 C, 1 min at 54 C,
30 s at 72 C, and 5 min at 72 C, and PCR products were resolved in
ethidium-bromide stained agarose gels.
2.3. Collection of primate samples
Tissue samples were obtained from carcasses found mainly in
Taï NP, Co^te d'Ivoire. Furthermore, necropsy samples were collected
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Uganda. Additional 16 tissue samples were obtained from sanctu-
aries from Gambia, Guinea, Sierra Leone, Cameroon, Republic of
Congo, Uganda, and two German zoos (Table 1). Finally, 13 fecal
samples were collected without disturbing the animals within
2e3 min after defecation and ﬁxed in 96% ethanol.
DNA extractions and PCR were performed in physically isolated
facilities. DNA from tissue samples and feces was extracted using
the DNAeasy tissue kits (Qiagen, Venlo, Limburg, Netherlands) and
the EURx Gene Matrix Stool Kit (Roboklon), respectively. All
amplicons were gel-puriﬁed using the Gel Extraction Kit (Qiagen,
Venlo, Limburg, Netherlands) and cloned in TOPO TA Cloning
(Invitrogen, Carlsbad, CA, USA) as speciﬁed by the manufacturer.
Samples positive for ITS1 in nested PCR reactions were further
analyzed for the presence of the ~900 bp-long T. b. gambiense
glycoprotein (TgSGP) gene, again via nested PCR, using outer
primers 65-F (50-GTGGCAATTACTAGCAATAGCG-30) and 66-R (50-
GCCATCGTGCTTGCCGCTC-30), and inner primers 61-F (50-
TCACGGCCATCAGACGGAGA-30) and 62-R (50-
GGGCTCCTGCCTCAATTGCTGCA-3). Conditions were the same for
both rounds: 2 min at 95 C, 24 cycles of 1 min at 95 C, 1 min at
55 C, 2 min at 72 C, and 2 min at 72 C. As a positive control, DNA
from blood of mouse experimentally infected with T. b. gambiense
(LiTat 1.3) was used.2.4. Phylogenetic analysis
Highly polymorphic ITS1 sequences obtained by nested PCR
from primate fecal and tissue samples were aligned with Clustal-X
(ver. 2.0; gap opening penalty 12; gap extension penalty 5) and
neighbor joining clustering with K2P distances was performed on
the unmodiﬁed alignment using PAUP (4.0, beta version). The ﬁnal
alignment included 452 characters. The accession numbers of se-
quences retrieved from the GenBank (Trypanosoma sp. ex Wilde-
beest JN673403, for Trypanosoma theileri JX178185, HQ664848, and
HQ664849) and used in phylogenetic reconstructions and ITS1
alignment are available from the authors upon request.Table 1
Summary of primate samples investigated for the presence of trypanosomes.
Site (country) Primate species Origin
Taï NP (Co^te d'Ivoire) Western chimpanzee Wild
Sooty mangabey Wild
Western red colobus Wild
Black-and-white colobus Wild
River Gambia NP (Gambia) Chimpanzee Semi-captiv
Chimpanzee Sanctuary
(Guinea)
Western chimpanzee Captive
Budongo NP (Uganda) Eastern chimpanzee Wild
Kasyoha-Kitomi FR (Uganda) Eastern chimpanzee Wild
Lui Kotale (DRC) Western red colobus Wild
ND Pennant's red colobus Wild
Limbe Wildlife Centre (Cameroon) Western lowland gorilla Semi-captiv
ND (Kongo) Western lowland gorilla Captive
ND (Kongo) Chimpanzee Captive
Ngamba (Uganda) Chimpanzee Semi-captiv
Tacugama (Sierra Leone) Chimpanzee Semi-captiv
Limbe Wildlife Centre (Cameroon) Chimpanzee Captivity
Munster Zoo (Germany) Colobus monkey Captivity
Frankfurt Zoo (Germany) Western lowland gorilla Captivity
Suma
T-pos. e Trypanosome-positive; NP e National Park; FR e Forest Reserve; % e prevalence
Congo. Western chimpanzee e Pan troglodytes verus, Eastern chimpanzee e Pan t. schw
gorilla, Western red colobus e Piliocolobus badius, Pennant's red colobus e P. pennantii,
a Several samples were collected from one individual.2.5. Trypanosome lysis in primate sera
We used fresh sera from ﬁve non-human primate species
(barbary macaque [Macaca sylvanus], mandrill [Mandrillus sphinx],
spider monkey [Ateles geoffroyi], chimpanzee [Pan troglodytes],
and Sumatran orangutan [Pongo abelii]) from the Plzen, Liberec
and Prague zoos, Czech Republic. At ﬁnal concentration of 10% the
sera were added to trypanosomatids cultivated in either HMI-9 or
M199 medium with 10% fetal bovine serum (FBS), when concen-
tration reached 5  105 cells/ml. The following isolates were used:
T. b. brucei (STIB 920), T. b. rhodesiense (Etat 1.2 R variant), and T. b.
gambiense (LiTat 1.3). Fresh normal human serum (NHS) obtained
from a Central European individual and FBS were used as positive
and negative controls, respectively. Trypanosomatids were
cultivated in triplicate with the various primate sera for 24 h at
37 C. After this period, resazurin (SigmaeAldrich, St. Louis, MO,
USA) was added to 1 ml of each culture (ﬁnal concentration
58 pM) and cell viability was measured after 24 h (i.e. 48 hrs after
the cells were mixed with primate sera) in triplicate using Tecan
Inﬁnite M200PRO under emission at 590 nm and excitation at
560 nm, and the results were analyzed using Anova. The relative
survival was calculated as a ratio in a given serum compared to
FBS.3. Results
3.1. Detection of trypanosomes in feces of experimentally infected
mice
Using the nested PCR protocol, the ITS1 region of T. b. brucei, T. b.
gambiense, T. b. rhodesiense and T. b. evansi was successfully
ampliﬁed from DNA isolated from fecal samples of infected mice,
with relevant controls being negative (Fig. 1). Single abundant
amplicons were of expected size (~450 bp) and sequence (Fig. 2).
This experiment proved that under our experimental conditions,
the ﬂagellate DNA can be reliably detected in feces of laboratory
mice using a 35 cycle PCR protocol.Examined/T-pos.
Individuals (%)
Examined/T-pos.
samples (%)
DNA source of T-pos.
samples
16/8 28/11 (39) Spleen (4), liver (3),
lymph node (1); feces
(3)a
10/1 10/1 (10) Liver
18/2 18/2 (11) Blood
5/0 5/0 e
e 1/1 2/2 (100) Spleen, livera
1/1 2/1 (50) Liver
9/1 9/1 (11) Liver
1/0 1/0 e
2/2 5/2 (40) Spleen
3/0 3/0 e
e 3/0 5/0 e
1/0 1/0 e
1/0 1/0 e
e 27/0 27/0 e
e 6/0 8/0 e
1/0 1/0 e
3/0 4/0 e
1/0 2/0 e
109/16 (15%) 132/20 (15%)
; sanctuary ND e not determined (from sanctuary); DRC e Democratic Republic of
einfurthii, Chimpanzee e Pan troglodytes, Western lowland gorilla e Gorilla gorilla
Black-and-white colobus e Colobus polykomos, Sooty mangabey e Cercocebus atys.
Fig. 1. ITS1-based detection of trypanosomes in blood and feces of experimentally
infected mice. (AeD, I) detection in blood; (EeH, J) detection in feces. (A, E) Trypa-
nosoma b. brucei; (B, F) T. b. gambiense; (C, G) T. b. rhodesiense; (D, H) T. b. evansi; (I)
blood from a non-infected mouse; (J) feces from a non-infected mouse; (K) negative
control; (m) marker.
Fig. 2. ITS1-based dendogram of trypanosomes from primate tissue and fecal samples.
Sequences generated in this study are marked as follows: T e tissue samples of apes
(TA) and monkeys (TM); F e fecal samples of apes (FA); sequences retrieved from
GenBank are labeled with Latin names (Trypanosoma sp. ex Wildebeest JN673403, for
T. theileri JX178185, HQ664848, and HQ664849).
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analysis
Overall, 132 samples composed of 119 various tissues and 13
feces, collected from 109 individual primates belonging to six
species were subjected to diagnostic PCR with trypanosome-
speciﬁc primers (Tables 1 and 2). Nested PCR protocol established
to amplify ITS1 from the fecal-derived DNA of laboratory-infected
mice (Fig. 1) was applied to DNA isolated from the tissue and
fecal samples. The sequences of amplicons obtained from 17 pri-
mate tissue samples were subjected to BLAST analysis, aligned and
grouped in a dendrogram, which showed that our sequences
belong to the T. brucei group (Fig. 2, see below).Since in the experimentally infected mice, the ITS1-speciﬁc
primers were able to amplify the target region of trypanosomes
from the fecal samples, we have performed the same PCR on DNA
isolated from fecal samples of wild chimpanzees. Out of 13 freshly
collected feces, threewere positive for trypanosome DNA (Fig. 2), as
conﬁrmed by sequencing. DNA isolated from the same samples and
analyzed independently in another laboratory by the same method
lead to identical results.
Next, we have generated an alignment from all ITS1 sequences
(for detail see Table 2) ampliﬁed from the tissue samples of chim-
panzees (number of samples ¼ 12), sooty mangabeys (n ¼ 1) and
Western red colobus monkeys (n ¼ 4), and also from the feces of
chimpanzees (n¼ 3) (Table 2). The dataset was complementedwith
relevant sequences available in GenBank, with Crithidia fasciculata
used as outgroup. With two exceptions (TA11 and TA12, see Fig. 2),
all newly obtained sequences fell into the T. brucei clade, as shown
by a neighbor joining dendrogram (Fig. 2). The T. brucei clade
contains sequences from all known subspecies and is characterized
by extremely short branches, which is not surprising given the
known minimal differences among individual subspecies. A total of
15 sequences obtained from the tissues of chimpanzees, Western
red colobus monkeys and a sooty mangabey fell into this clade, as
well as three sequences obtained from the feces of three chim-
panzees, providing strong evidence for the infections by the
T. brucei group parasites (Table 2; Fig. 2).
All our attempts to amplify the TgSGP gene speciﬁc for T. b.
gambiense (Capewell et al., 2013b) from the tissues and feces of
apes positive for Trypanosoma ITS1 PCR assay invariably failed,
although this gene can be easily ampliﬁed from feces and blood of
mice infectedwith this T. brucei subspecies (Supplementary data 1).
Out of 18 positive samples belonging to the T. brucei clade, two
samples, one from a spleen and second one from a lymph node of
two post-mortem dissected wild Western chimpanzees originating
from Taï NP, Co^te d'Ivoire, fell outside of the T. brucei clade (Table 2;
Fig. 2). While TA 11 is almost identical with an unnamed Trypano-
soma sp. (Access. No. JN673403) from a wildebeest (Connochaetes)
captured in Serengeti NP, Tanzania, TA 12 from an adult female
chimpanzee from Taï NP is strongly afﬁliated with T. theileri (Fig. 2).
Due to the limited information residing in the obtained ITS1
region, multiple attempts to amplify (fragments of) the SSU rRNA
gene of the above-described pathogens were performed seeking to
establish more precisely their species status. Unfortunately, these
attempts almost invariably failed. However, in the case of the TA 12
tissue sample, a fragment of the SSU rRNA gene was successfully
ampliﬁed which allowed us to assign the respective parasite with
high conﬁdence to T. theileri.3.3. Trypanolytic capacity of primate sera
Onlymandrill and human sera (NHS) efﬁciently lysed T. b. brucei,
with relative survival 0.101 ± 0.005 (mean ± SD; p < 0.001) and
0.068 ± 0.074 (p < 0.001), respectively (Supplementary data 2).
When the cultured T. b. gambiense cells were subjected to the panel
of different sera, the lytic factor allowing their limited killing was
present only in the mandrill's serum (0.488 ± 0.087; p < 0.001). As
anticipated, NHS failed to lyse T. b. gambiense, with a relative sur-
vival of 0.886 ± 0.170 (p > 0.05) (Supplementary data 2), while this
pathogen also prospered in the other sera. The cultured T. b. rho-
desiense cells were very efﬁciently lysed by the mandrill serum
(0.138 ± 0.001; p < 0.001), with the sera of spider monkey and
orangutan showing a moderate lysis (0.837 ± 0.054, p < 0.01 and
0.848 ± 0.067, p < 0.01 respectively). Under our conditions, NHS
caused a very minor yet signiﬁcant lysis as well (0.874 ± 0.075;
p < 0.05).
Table 2
List of primate samples positive for Trypanosoma spp. DNA.
Primate species DNA source Country/origin Label of ITS1 sequence GenBank no.
Western chimpanzeea Spleen Co^te d'Ivoire/wild TA 01 (2.500-32R; 10.2) KR092349
Western chimpanzee Spleen Co^te d'Ivoire/wild TA 06 (9.1; 558.8) KR092354
Western chimpanzee Spleen Co^te d'Ivoire/wild TA 10 (1.300-16R; 1.37) KR092358
Western chimpanzee Spleen Co^te d'Ivoire/wild TA 12 (22.1; 559.2) KR092365
Western chimpanzee Liver Co^te d'Ivoire/wild TA 04 (1.800-26R; 77.2.1) KR092352
Western chimpanzeea Liver Co^te d'Ivoire/wild TA 08 (3.1; 10.5) KR092356
Western chimpanzee Liver Co^te d'Ivoire/wild TA 09 (4.450-38R; 4.7) KR092357
Western chimpanzee Liver Republic of Guinea/captive TA 02 (2.1; 34.9) KR092350
Western chimpanzee Lymph node Co^te d'Ivoire/wild TA 11 (19; 559.4) KR092364
Western chimpanzee Feces Co^te d'Ivoire/wild FA 01 (21.3; F627.3) KR092346
Western chimpanzee Feces Co^te d'Ivoire/wild FA 02 (138-113R; F325.2) KR092347
Western chimpanzee Feces Co^te d'Ivoire/wild FA 03 (7.1; F77.24) KR092348
Eastern chimpanzee Liver Uganda (Budongo NP)/wild TA 05 (1.500-19R; 501.3) KR092353
Chimpanzeea Spleen Gambia/semi-captive TA 03 (60-4R; 347.2) KR092351
Chimpanzeea Liver Gambia/semi-captive TA 07 (59-3R; 347.1) KR092355
Sooty mangabey Liver Co^te d'Ivoire/wild TM 01 (131-103R;844.5) KR092359
Red colobus Spleen DRC/wild TM 02 (1.450-35R; 106.1.1) KR092360
Red colobus Spleen DRC/wild TM 03 (1.500-21R; 108.1.) KR092361
Western red colobus Blood Co^te d'Ivoire/wild TM 04 (2.300-30R; 30.1) KR092362
Western red colobus Blood Co^te d'Ivoire/wild TM 05 (2.500-33R; 765.1) KR092363
a The same individual.
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Within the last decade it has become abundantly clear that Af-
rican great apes play a signiﬁcant role in evolution, emergence, and
transmission of a range of infectious diseases important for human
populations. Simian immunodeﬁciency viruses and apicomplexan
parasites of the genus Plasmodium are among the best known ex-
amples (Liu et al., 2010; Calvignac-Spencer et al., 2012; Liu et al.,
2014). Although the wild chimpanzees and other African great apes
live in regions endemic for African sleeping sickness, the research
on their trypanosome infections has been neglected. This situation
is mostly caused by the virtually insurmountable difﬁculties in
obtaining blood samples from free-ranging animals and ethical
unacceptability of experimental infections on captive animals.
Interestingly, African primates exhibit a widely different degree
of resistance against parasites of the T. brucei group (Wheeler,
2010). In the literature, there are only very few notes on ﬂagel-
lates found in the blood of dead free-ranging chimpanzees, without
any evidence that their death was a consequence of trypanosomi-
asis (Hoare, 1972). Early experimental infections of chimpanzees
with different subspecies of T. brucei led to controversial results:
while T. b. brucei and T. b. rhodesiense resulted in fatal parasitemia
(Baker, 1962, 1968; Godfrey and Killick-Kendrick, 1967; Baker and
Taylor, 1971), T. b. gambiense did not cause any obvious pathology
despite the presence of trypomastigotes in the cerebro-spinal ﬂuid
(Godfrey and Killick-Kendrick, 1967; Hoare, 1972). This suggests
that chimpanzees might serve as reservoir hosts for T. b. gambiense.
Moreover, recent results demonstrated the existence of trypano-
somatid hybrids among some subspecies of the T. brucei group,
which have various animal reservoirs and are capable of infecting
humans (Tait et al., 2011; Capewell et al., 2013a; Duffy et al., 2014;
Echodu et al., 2015). Hence, addressing the question whether the
free-ranging non-human primates may serve as a host or reservoir
for some of these trypanosomes is relevant.
Inspired by recent advances in our understanding of mecha-
nisms of resistance to trypanosomes mediated by the TLF (Raper
and Friedman, 2013), we performed the experiments, in the
frame of which three subspecies of the T. brucei group were
incubated with sera from mandrill, barbary macaque, spider
monkey, orangutan and chimpanzee. The obtained results on T. b.
brucei and T. b. gambiense are in concordance with previous ex-
periments of Lugli et al. (2004), though we also demonstrated thatthe serum from a mandrill is able to also lyse T. b. gambiense.
Furthermore, the chimpanzee sera failed to lyse T. b. brucei, T. b.
rhodesiense and also T. b. gambiense. However, results obtained
with the latter subspecies are in contrast with the early infection
experiments (Baker, 1962, 1968; Godfrey and Killick-Kendrick,
1967; Baker and Taylor, 1971), perhaps due to the fact that those
have been conducted on animals originating from nature. This
indicates that wild chimpanzees could have a (partial) resistance
to T. b. gambiense, especially in the endemic regions. Our experi-
ment conﬁrmed the notion that chimpanzees are fully susceptible
to T. b. brucei, against which humans and other primates devel-
oped efﬁcient resistance (Xong et al., 1998; Raper and Friedman,
2013; Uzureau et al., 2013; Thomson et al., 2014). These results
suggest that the transmission of any of the T. brucei group ﬂa-
gellates into the blood of chimpanzees shall result into an
infection.
Inspired by successful detection of the Plasmodium DNA in pri-
mate feces (Liu et al., 2010; Jirku et al., 2012), we proved the ability
of ITS1-based PCR assay to amplify the DNA of all four T. brucei
subspecies in feces of experimentally infected mice. PCR-based
screening of the available set of fecal samples from wild chim-
panzees revealed the presence of trypanosomes, and this ﬁnding
was further supported by positive results from a number of tissue
samples taken from dead chimpanzees. By allowing the detection
of trypanosomes in feces, this assay overcomes the inaccessibility of
blood and tissue samples from animals that are endangered in the
wild. This detectionmethod provides new opportunities for studies
of trypanosomatid parasites in the African great apes, and poten-
tially in other rare or highly endangered mammals.
Our dendogram of the ITS1 region showed that absolute ma-
jority of the obtained sequences fell into the robust T. brucei clade,
providing strong evidence that these infections were caused by one
of its subspecies. However, since all attempts to amplify T. b. rho-
desiense and T. b. gambiense-speciﬁc DNA regions failed, the sub-
species status could not be established. In any case, the
introduction of a PCR assay, capable of amplifying trypanosome
DNA from the feces of great apes and potentially other infected
mammals, will allow non-invasive large-scale screening for these
important parasites. In summary, via feces- and tissue-based PCR
assays, we have demonstrated that chimpanzees are frequently
infected with trypanosomes from the T. brucei group and rarely also
by other species. Future research might shed light on how
M. Jirku et al. / International Journal for Parasitology: Parasites and Wildlife 4 (2015) 277e282282chimpanzees control trypanosomiasis, and whether transmission
occurs among them, other primates and humans.
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